ACHE and early-onset autosomal dominant Alzheimer disease: Donepezil, galantamine, and rivastigmine are the only acetylcholinesterase inhibitors currently approved by both the FDA and EMA for the treatment of Alzheimer’s disease (Figure 2) [38,39].